HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe
about
Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa.Aerobic endurance in HIV-positive young adults and HIV-negative controls in Malawi.Anemia, diet and therapeutic iron among children living with HIV: a prospective cohort study.Practical Management of HIV-Associated Anemia in Resource-Limited Settings: Prospective Observational Evaluation of a New Mozambican GuidelineAntiretroviral Treatment Efficacy and Safety in Older HIV-Infected Adults.
P2860
HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HIV-associated anemia after 96 ...... ranges in Uganda and Zimbabwe
@ast
HIV-associated anemia after 96 ...... ranges in Uganda and Zimbabwe
@en
type
label
HIV-associated anemia after 96 ...... ranges in Uganda and Zimbabwe
@ast
HIV-associated anemia after 96 ...... ranges in Uganda and Zimbabwe
@en
prefLabel
HIV-associated anemia after 96 ...... ranges in Uganda and Zimbabwe
@ast
HIV-associated anemia after 96 ...... ranges in Uganda and Zimbabwe
@en
P2093
P2860
P356
P1476
HIV-associated anemia after 96 ...... ranges in Uganda and Zimbabwe
@en
P2093
A Sarah Walker
ARROW Trial
Cissy Kityo
DART Trial
Francis Kiweewa
Francis Ssali
Peter Mugyenyi
Robert Salata
P2860
P304
P356
10.1089/AID.2013.0255
P577
2014-02-07T00:00:00Z